ÂÜÀòÂÒÂ×

Tess Lin is currently the Director of Study Clinician in Early Clinical Development for Oncology at Pfizer. They previously held various roles, including Associate Director of Clinical Development at Progenics Pharmaceuticals and a Clinical Drug Development and Regulatory Affairs Fellow at GSK. Tess has extensive experience in clinical research and regulatory affairs, having interned at several organizations including National Taiwan University Hospital and Arbor Communications. They earned a Doctor of Pharmacy from the University of Michigan College of Pharmacy and a Bachelor of Science in Microbiology, Immunology, and Molecular Genetics from UCLA.